Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

Roche’s Lunsumio granted Priority Review by FDA for people with relapsed or refractory follicular lymphoma

If approved, this could be the first such antibody approved by the FDA for the treatment of any type of non-Hodgkin lymphoma

- PMLiVE

Pfizer’s Paxlovid given FDA permission to be prescribed by US pharmacists

Under the Emergency Use Authorisation revision, pharmacists will be able to prescribe the COVID-19 treatment to patients, providing they meet certain conditions

- PMLiVE

BeiGene and InnoRNA join to research novel mRNA therapies

BeiGene will hold exclusive global development and commercialisation rights for the jointly discovered mRNA-LNP therapies

- PMLiVE

Diabetes management – should there be a ‘one-size fit all’ approach?

For Diabetes Awareness Week 2022, we discussed diabetes as a chronic condition, and the increasing importance of home-based disease management.

IGNIFI

- PMLiVE

Cannes Lions shows health creative is becoming an art form

Painting a portrait of health at this year’s Festival of Creativity – and the picture is looking good

- PMLiVE

The Power of AI in Medical Education

Artificial intelligence (AI) is a rapidly growing field with many applications in the world of medicine, including continuing medical education. Ritu Kumar, Medscape lead data scientist, explains how Medscape Education...

Medscape Education

- PMLiVE

FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease

Lecanmab is being evaluated in the ongoing phase 3 Clarity Alzheimer's clinical trial

- PMLiVE

New Swiss research reveals how Omicron evades the immune system

A team from the University of Geneva and the Geneva University Hospital analysed the antibody neutralisation capacity of 120 people previously infected with one of the different COVID-19 variants

- PMLiVE

Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021

Evoke KYNE took home the Communiqué Communications Consultancy of the Year award at the 2021 Communiqué Awards held on 1 September at the Grosvenor House hotel in London.David Kyne, CEO, Evoke KYNE said:...

Inizio

- PMLiVE

Michael Grela Elected President of the Society for Health Communication

February 8, 2022 – Michael Grela, Evoke KYNE’s EVP, Head of Reputation and Social Impact, has been elected President of the Society for Health Communication, a member-driven organization working to advance the science...

Inizio

- PMLiVE

Evoke Kyne Appoints Maureen Byrne to President and Promotes Four Executive Leaders

New York, April 27, 2022 – Evoke KYNE, an award-winning health communications agency, today announced the appointment of Maureen Byrne to President. Byrne will assume global leadership responsibilities from David Kyne including management of its...

Inizio

- PMLiVE

First evidence-based guide launched to put patients at heart of digital innovations

Produced by the University of Plymouth, the Academic Health Science Network and Boehringer Ingelheim, the guide follows the UK government’s plan to revolutionise digital health and social care

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links